ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jiping Zha, MD, PhD
Adagene Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fujian Cancer Hospital
Fuzhou, Fujian, China
Recruiting - Sunyat-Sen University Cancer Center
Guangzhou, Guangdong, China
Recruiting - Hong Kong Humanity & Health Clinical Trial Center
Hong Kong, Hong Kong, China
Recruiting - Prince of Wales Hospital
Hong Kong, Hong Kong, China
Recruiting
- Dong -A University Hospital
Seogu, Busan Gwangyeogsi, South Korea
Terminated - Cha Bundang Medical Center, Cha University
Seongnam, Gyeonggido, South Korea
Recruiting - the Catholic University of Korea Street. Vincent Hospital
Suwon, Gyeonggido, South Korea
Terminated - Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea
Recruiting - Samsung Medical Center
Seoul, Seoul Teugbyeolsi, South Korea
Recruiting - Keimyung University Dongsan Hospital
Daegu, South Korea
Terminated - Asan Medical Center
Seoul, South Korea
Recruiting - Kangbuk Samsung Hospital
Seoul, South Korea
Terminated - Seoul National University Hospital
Seoul, South Korea
Recruiting - Severance Hospital Yonsei University Health System
Seoul, South Korea
Recruiting
- Honor Health Research Institute
Scottsdale, Arizona, United States
Recruiting - City of Hope National Medical Center
Duarte, California, United States
Recruiting - City of Hope Orange County
Irvine, California, United States
Recruiting - Florida Cancer Specialist/sarah Cannon Research Institute
Sarasota, Florida, United States
Active, not recruiting - the Cleveland Clinic
Cleveland, Ohio, United States
Recruiting - Md Anderson Cancer Center
Houston, Texas, United States
Recruiting - Fred Hutchinson Cancer Center
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jun 2022
- Primary completion
- 31 Oct 2026
- Completion
- 30 Apr 2027
- Last update posted
- 7 Jan 2026
- Registered enrollment
- 186
- Registry id
- NCT05405595
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.